Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Koru Medical Systems Inc
(NQ:
KRMD
)
4.400
+0.530 (+13.70%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Koru Medical Systems Inc
< Previous
1
2
3
4
5
Next >
KORU Medical Systems to Participate in Upcoming Investor Conferences
November 10, 2022
From
KORU Medical Systems
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
November 10, 2022
Upgrades
Via
Benzinga
KORU Medical Systems Announces 2022 Third Quarter Financial Results
November 09, 2022
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems: Q2 Earnings Insights
August 03, 2022
KORU Medical Systems (NASDAQ:KRMD) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
KORU Medical Systems Announces Novel Therapy Collaboration for Three Indications with Kira Pharmaceuticals
November 08, 2022
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems to Report Third Quarter 2022 Financial Results on November 9, 2022
October 26, 2022
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems to Participate in Upcoming Industry Conferences
October 17, 2022
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems Appoints Brent Rutland as Vice President of Medical Affairs
October 12, 2022
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems Joins Subcutaneous Drug Development & Delivery Consortium
October 05, 2022
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems Announces 2022 Second Quarter Financial Results
August 03, 2022
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems to Report Second Quarter 2022 Financial Results on August 3, 2022
July 20, 2022
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems Announces 2022 First Quarter Financial Results
May 04, 2022
From
KORU Medical Systems
Via
Business Wire
Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday
June 24, 2022
Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 263% to $2.73 on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown...
Via
Benzinga
KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of EMPAVELI® (pegcetacoplan), Expands European Label for FreedomEdge®
May 02, 2022
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems to Report First Quarter 2022 Financial Results on May 4, 2022
April 20, 2022
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems Appoints Brian Case As Chief Technology Officer
April 18, 2022
From
KORU Medical Systems
Via
Business Wire
Preview: Repro-Med Systems's Earnings
March 01, 2022
Repro-Med Systems (NASDAQ:KRMD) is set to give its latest quarterly earnings report on Wednesday, 2022-03-02. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
CORRECTING and REPLACING KORU Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022
February 22, 2022
From
KORU Medical Systems
Via
Business Wire
Earnings Scheduled For March 2, 2022
March 02, 2022
Companies Reporting Before The Bell • SIGNA Sports United (NYSE:SSU) is expected to report quarterly loss at $0.04 per share on revenue of $283.61 million. •...
Via
Benzinga
KORU Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2021
February 16, 2022
From
KORU Medical Systems
Via
Business Wire
The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda
December 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Allakos's Lirentelimab Flunks Late-Stage Studies In Patients With...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 21, 2021
Gainers BioRestorative Therapies (NASDAQ:BRTX...
Via
Benzinga
KORU Medical Systems Receives FDA 510(k) Clearance for the Use of the FREEDOM60® with Two Additional SCIg Drugs
December 21, 2021
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems to Unveil Updated Strategic Plan at Investor Day
December 01, 2021
From
KORU Medical Systems
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 12, 2021
Gainers Sundial Growers (NASDAQ:SNDL) stock increased by 28.49% to $0.93 during Friday's pre-market session. The market value of their outstanding shares is at $1.9...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 11, 2021
Gainers Liquidia (NASDAQ:LQDA) stock inc...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 11, 2021
Gainers ADMA Biologics (NASDAQ:ADMA) shares moved upwards by 11.42% to $1.56 during Thursday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
91 Biggest Movers From Yesterday
November 12, 2021
Gainers NuZee, Inc. (NASDAQ: NUZE) shares jumped 164.5% to settle at $5.29 on Thursday. NuZee manufacturing partner, Cuvee Coffee, reported an expansion into select Walmart...
Via
Benzinga
54 Stocks Moving In Thursday's Mid-Day Session
November 11, 2021
Gainers Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares gained 42.6% to $9.68. Pioneer Power Solutions recently announced the launch of its E-Boost portfolio of mobile...
Via
Benzinga
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
November 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Commences Late-Stage Study Of Heart Failure Treatment Merck &...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.